Salk researchers uncover molecular mechanisms of HIV drug resistance

Salk Institute researchers, in collaboration with the National Institutes of Health, have discovered the molecular mechanisms by which the human immunodeficiency virus (HIV) becomes resistant to Dolutegravir, one of the most effective, clinically used antiviral drugs for treating HIV.

Related Keywords

Dmitry Lyumkis ,Indrani Choudhuri ,Allan Haldane ,Avik Biswas ,Stephenh Hughes ,Mamuka Kvaratskhelia ,Timothys Strutzenberg ,Nanjie Deng ,Dario Oliveira Passos ,Robert Craigie ,Megan Craig ,Zhaoyang Li ,Zelin Shan ,Xue Zhi Zhao ,Stevenj Smith ,Terrencer Burke Jr ,Qinfang Sun ,Lorenzo Briganti ,Salk Institute ,National Institutes Of Health ,University Of Colorado Anschutz Medical Campus ,National Cancer Institute ,Intramural Program ,Margarett Morris Foundation ,Intramural Targeted Program ,Cancer Research ,National Institute Of Diabetes ,Hearst Foundation Developmental ,Ronaldm Levy Of Temple University ,Pace University ,Hearst Foundation ,National Institutes ,Science Advances ,Salk Associate Professor ,Co Senior Author ,National Institute ,Kidney Diseases ,Temple University ,Colorado Anschutz Medical ,Targeted Program ,Shiv ,Protein ,Dancer ,Na ,Drugs ,Mmunodeficiency ,Herapeutics ,Virus ,